Deargen Companies

Deargen provides AI-based genome analysis service.

Last Funding Type: Series B
Funding Status: Early Stage Venture
Headquarters: Daejeon, Taejon-jikhalsi, South Korea
Founded Date: 2016-12-06
Investor Type: N/A
Investment Stage: N/A
Last Funding Date: 2022-02-24
Total Funding: 19647275.0
Technology: COVID
Employee Number: 11-50
Number Of Exists: N/A
Investors Number: 6.0
Industry: BioTech & Health Care